Loading...
Market
Outcome of McKesson's appeal in Baltimore opioid case if filed by March 31, 2025
3
Resolution / Starting Odds
Appeal successful • 25%
Appeal partially successful • 25%
Appeal unsuccessful • 25%
No appeal filed • 25%
Court rulings and legal records
Story
McKesson and AmerisourceBergen to Pay $260M for Role in Baltimore's Opioid Crisis, Jury Rules Tuesday
Nov 12, 2024, 07:17 PM
A jury has found two drug distributors, McKesson and AmerisourceBergen, liable for contributing to Baltimore’s opioid crisis. The companies have been ordered to pay more than $260 million in damages. Baltimore alleged that the drug distributors fueled the city’s opioid epidemic by sending hundreds of millions of addictive painkillers to the area with little regard for the havoc they could wreak. This ruling is part of a broader national effort to hold companies accountable for their roles in the opioid crisis. The jury's decision was made on Tuesday.
View original story
Similar markets
Settlement • 25%
Trial verdict • 25%
Dismissal • 25%
Other • 25%
Settlement finalized at $500M • 25%
Settlement finalized above $500M • 25%
Settlement finalized below $500M • 25%
No settlement finalized • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
New lawsuit against another consulting firm • 25%
New lawsuit against pharmaceutical company • 25%
Introduction of new regulations • 25%
No major action • 25%
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
Other • 25%
U.S. Department of Justice • 25%
Federal Trade Commission • 25%
Securities and Exchange Commission • 25%
Other • 25%
Financial settlement reached • 25%
Case dismissed • 25%
Case goes to trial • 25%
Other • 25%
Settlement reached • 25%
CVS found liable • 25%
CVS not found liable • 25%
Case dismissed • 25%
